National | July 24, 2026:
Synopsis
- Partnership: Oriflame enters into agreement with Pure and Cure Healthcare Pvt. Ltd., a wholly-owned subsidiary of Akums Drugs and Pharmaceuticals Ltd.
- Facilities: Transaction includes Oriflame’s manufacturing sites in Roorkee, Uttarakhand and Noida, Uttar Pradesh.
- Strategic Arrangement: Long-term manufacturing and supply partnership to ensure continuity of Oriflame products.
- Commitment: India remains a strategically important market for Oriflame, with operations continuing through its Beauty Entrepreneur network.
- Employees: Current staff at manufacturing sites will continue employment under the new owner on the same terms.
Announcement
Oriflame, the Swedish holistic beauty and wellbeing brand, has announced a strategic manufacturing partnership with Akums Drugs and Pharmaceuticals Ltd., one of India’s leading contract development and manufacturing organisations (CDMOs).
Under the agreement, Oriflame will transfer its manufacturing operations in India to Pure and Cure Healthcare Pvt. Ltd., a wholly-owned subsidiary of Akums. The transaction includes Oriflame’s facilities in Roorkee and Noida, subject to customary closing conditions and regulatory approvals.
As part of the partnership, Akums will continue to manufacture Oriflame products, ensuring continuity of supply and maintaining the high standards of quality expected by Oriflame Beauty Entrepreneurs and customers.
Anna Malmhake, CEO & President, Oriflame: “India is an important market for Oriflame and we remain fully committed to our long-term growth ambitions in the country. Through this strategic partnership with Akums, we are securing access to high-quality manufacturing capabilities while enabling greater operational flexibility and alignment with our sourcing strategy. We are pleased to be partnering with a trusted and reputable manufacturer that shares our commitment to quality and excellence.”
Edyta Kurek, Senior Vice President & GM, Oriflame India: “Oriflame’s manufacturing standards in India have been built over more than three decades of expertise at our Roorkee and Noida facilities. Our partnership with Akums reflects our philosophy of building long-term, sustainable collaborations that uphold the highest standards of quality. For our Beauty Entrepreneurs and customers, it is business as usual, with our commercial operations, products, and services remaining unchanged. We are pleased that the partnership is intended to ensure continuity for employees while preserving the expertise built within these facilities.”
Strategic Impact
- Ensures continuity of Oriflame products for Beauty Entrepreneurs and customers.
- Preserves employment and expertise at Roorkee and Noida facilities.
- Strengthens Oriflame’s global operations and sourcing footprint.
- Reinforces Oriflame’s commitment to India, where it has operated for over 30 years.
About Oriflame
Founded in 1967, Oriflame is a globally renowned beauty and wellbeing company operating in over 60 markets.
- Empowers individuals through a diverse portfolio of skincare, cosmetics, fragrances, personal care, and nutritional supplements.
- Operates via a modern social selling model, enabling over 3 million Beauty Entrepreneurs worldwide to build micro-entrepreneurship opportunities.
- Recognised as a European Climate Leader by the Financial Times and Statista for five consecutive years.
- In India, Oriflame continues to build opportunities for women to achieve financial independence while promoting holistic wellbeing.
About Akums Drugs and Pharmaceuticals Ltd.
Akums is one of India’s leading contract development and manufacturing organisations (CDMOs), known for its expertise in pharmaceutical manufacturing and healthcare solutions. Through its subsidiary Pure and Cure Healthcare Pvt. Ltd., Akums will manage Oriflame’s transferred manufacturing operations in India, ensuring quality, reliability, and operational excellence.
